Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid na... Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. Show more
50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved...
WARMINSTER, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD - The Liver Meeting 2024 Multiple-ascending doses of AB-101 in healthy subjects in the...
WARMINSTER, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company leveraging its extensive...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.26 | -7.02702702703 | 3.7 | 3.81 | 3.42 | 1080511 | 3.56782011 | CS |
| 4 | -0.61 | -15.0617283951 | 4.05 | 4.1 | 3.42 | 811612 | 3.75720712 | CS |
| 12 | -0.41 | -10.6493506494 | 3.85 | 4.725 | 3.42 | 1154510 | 4.03231299 | CS |
| 26 | 0.34 | 10.9677419355 | 3.1 | 4.725 | 2.915 | 1058973 | 3.74702206 | CS |
| 52 | 1.63 | 90.0552486188 | 1.81 | 4.725 | 1.79 | 1058669 | 3.21878598 | CS |
| 156 | 0.17 | 5.19877675841 | 3.27 | 6.5 | 1.69 | 1752194 | 3.49313364 | CS |
| 260 | 1.92 | 126.315789474 | 1.52 | 9 | 0.88 | 2131659 | 3.71104499 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
